QUILT-2.008: Study of ALT-801 With Cisplatin in Patients With Metastatic Melanoma

This study has been completed.

Sponsor:

Collaborator:

National Cancer Institute (NCI)

Information provided by (Responsible Party):

Altor Bioscience Corporation

ClinicalTrials.gov Identifier:

NCT01029873

First received: December 9, 2009

Last updated: October 26, 2016

Last verified: October 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2013
Primary Completion Date:	November 2011 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	July 23, 2013